Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammation01:38

Inflammation

64.1K
Overview
64.1K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

1.9K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.9K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

948
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
948
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

577
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
577
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

1.6K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

593
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
593

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PCPE1 and PCPE2: When Sequence Similarity Masks Functional Diversity.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same author

Ancestral marriage cultures and first partnership choices of the children of immigrants.

Population studies·2025
Same author

Reassessing general explanations for long-run change in internal migration: Insights from Norway.

Population studies·2025
Same author

Honoring the Life and Legacy of Dr David A. Dichek.

Arteriosclerosis, thrombosis, and vascular biology·2025
Same author

Measles secondary vaccine failure in a childcare setting: an outbreak report.

Communicable diseases intelligence (2018)·2024
Same author

Apolipoprotein A-I Mimetic Peptide Restores VEGF-induced Angiogenesis in Hypercholesterolemic Ischemic Heart by Reducing HDL Proinflammatory Properties.

Journal of cardiovascular translational research·2024

Related Experiment Video

Updated: Mar 25, 2026

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
09:41

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions

Published on: October 17, 2017

14.1K

Microdomains, Inflammation, and Atherosclerosis.

Mary G Sorci-Thomas1, Michael J Thomas2

  • 1From the Division of Endocrinology, Metabolism and Clinical Nutrition, Department of Medicine and Senior Investigator, Blood Research Institute, BloodCenter of Wisconsin (M.G.S.-T.) and Department of Pharmacology and Toxicology (M.J.T.), Medical College of Wisconsin, Milwaukee, WI. msthomas@mcw.edu.

Circulation Research
|February 20, 2016
PubMed
Summary

Maintaining cellular cholesterol balance is crucial for preventing atherosclerosis. Free cholesterol (FC) and cholesteryl ester (CE) levels impact immune cell function and foam cell formation in arteries.

Keywords:
apolipoprotein A-Iatherosclerosischolesterolinflammationmembrane microdomains

More Related Videos

On-Chip Endothelial Inflammatory Phenotyping
12:43

On-Chip Endothelial Inflammatory Phenotyping

Published on: July 21, 2012

11.5K
A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites
09:52

A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites

Published on: August 8, 2014

18.2K

Related Experiment Videos

Last Updated: Mar 25, 2026

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
09:41

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions

Published on: October 17, 2017

14.1K
On-Chip Endothelial Inflammatory Phenotyping
12:43

On-Chip Endothelial Inflammatory Phenotyping

Published on: July 21, 2012

11.5K
A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites
09:52

A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites

Published on: August 8, 2014

18.2K

Area of Science:

  • Cardiovascular Biology
  • Atherosclerosis Research
  • Cellular Lipid Metabolism

Background:

  • Elevated cholesteryl ester (CE)-enriched apoB lipoproteins drive foam cell formation, initiating atherosclerosis.
  • Unregulated low-density lipoprotein cholesterol uptake by monocytes disrupts cellular cholesterol homeostasis via scavenger receptors.
  • Free cholesterol (FC) hydrolysis from lipoproteins can lead to CE re-esterification or efflux via ATP-binding cassette transporter A1.

Purpose of the Study:

  • To elucidate the role of cellular cholesterol homeostasis in immune cell function and atherosclerosis.
  • To investigate the impact of free cholesterol (FC) and cholesteryl ester (CE) balance on microdomain regulation and immune signaling.
  • To understand how apolipoprotein AI (apoAI) influences microdomain cholesterol and promotes foam cell regression.

Main Methods:

  • The study focuses on the cellular processing of lipoproteins and cholesterol within monocytes and peripheral blood cells.
  • It examines the mechanisms of free cholesterol (FC) handling, including esterification and ATP-binding cassette transporter A1-mediated efflux.
  • The role of lipid rafts and microdomains in cellular signaling and cholesterol regulation is investigated.

Main Results:

  • Dysregulation of FC/CE balance leads to accumulation of CE droplets and poorly regulated microdomain cholesterol.
  • Prolonged immune cell signaling activation and receptor oversensitization result from impaired cholesterol efflux.
  • Availability of apolipoprotein AI (apoAI) facilitates cholesterol efflux, reducing microdomain cholesterol burden and promoting foam cell regression.

Conclusions:

  • Cellular cholesterol homeostasis, balancing free cholesterol (FC) and cholesteryl ester (CE), is essential for proper immune cell function.
  • Maintaining this balance prevents chronic immune cell overstimulation, proliferation, and infiltration, crucial for preventing atherosclerosis progression.
  • Apolipoprotein AI (apoAI) plays a key role in regulating cellular cholesterol, alleviating microdomain cholesterol excess, and aiding foam cell regression.